Download Files:
Products Details
Product Description
– Mal-VC-PAB-PNP-CDN-A is a agent-linker conjugate for ADC[1][2].
Web ID
– HY-148399
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C51H67N17O20P2
References
– [1]Chen, Zhijian, et al. ANTIBODY-STING AGONIST CONJUGATES AND THEIR USE IN IMMUNOTHERAPY. Patent. US20210015941A1.|[2]Wang Y, et al. Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index. Drug Deliv. 2022 Dec;29(1):754-766.
CAS Number
– 2640880-35-7
Molecular Weight
– 1300.13
SMILES
– CC(C)[C@H](NC(CCCCCN1C(C=CC1=O)=O)=O)C(N[C@H](C(NC(C=C2)=CC=C2COC(NCC[C@@H]([C@@H](O3)[C@@H]4N5C=NC6=C5N=C(N)NC6=O)[C@H](O4)COP(O[C@H]7[C@@H](O)[C@H](N(C=N8)C9=C8C(N)=NC=N9)O[C@@H]7COP3(O)=O)(O)=O)=O)=O)CCCNC(N)=O)=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Drug-Linker Conjugates for ADC
Pathway
– Antibody-drug Conjugate/ADC Related
Product type
– ADC Related
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
